Addictions, Drug & Alcohol Institute

Events


May 29, 2026

RECORDING AVAILABLE: Executive Function and Communication in Early Adulthood in the Context of FASD (ADAI Lunch & Learn)

ADAI Lunch & Learn: Executive Function and Communication in Early Adulthood in the Context of FASD: Family Perspectives. Sara Kover, PhD, UW Dept. of Speech and Hearing Sciences. May 28, 2026, 12-1pm PT (virtual)

Sara Kover, PhD, of the UW Department of Speech & Hearing Sciences, joined ADAI for our May 2026 Lunch & Learn webinar. The recording from this session is now available! Dr. Kover’s presentation explored preliminary findings from a project designed to understand the values and experiences of individuals with FASD and their families during a…


May 4, 2026

Northwest ATTC Webinar: Direct to Inject (Buprenorphine) Strategies to Improve Care for People with SUD and Infectious Disease (May 20, 12pm PT)

Northwest ATTC: Syndemic Care for People Struggling with Substance Use Disorder (SUD) – Leveraging Direct to Inject (DTI) Strategies to Improve Care Integration, May 20, 2026, 12-1pm PT

Join the Northwest ATTC on May 20, 2026 (12-1pm PT) for their next webinar: Syndemic Care for People Struggling with Substance Use Disorder (SUD) – Leveraging Direct to Inject (DTI) Strategies to Improve Care Integration Presenter: Chris Bositis, MD, Clinical Director, UCSF National Clinician Consultation Center (NCCC) In spite of recent gains made in reducing new…


April 7, 2026

ADAI Lunch & Learn: Motivated Cannabis Compliance: Using Retail Incentives to Sell Safety (April 30, 12pm PT)

ADAI Lunch & Learn: Motivated Cannabis Compliance: Using Retail Incentives to Sell Safety Sarah Okey, PhD, WA State Liquor & Cannabis Board April 30, 2026, 12-1pm PT

In this month’s ADAI Lunch & Learn, Sarah Okey, PhD, Research Psychologist & Research Program Manager at the WA State Liquor and Cannabis Board, will showcase how the retail point-of-sale is one of the most critical interventions for consumer safety. Over 90% of adults who buy cannabis at Washington retail stores ask staff questions about what…


Upcoming Trainings: Two Depressants, One Conversation: Addressing Alcohol Use Among People with OUD (April/May 2026)

Two depressants, one conversation

Alcohol use is common among people who use opioids, including fentanyl. Alcohol worsens health, complicates treatment, and increases overdose risk. The good news? There are ways to help people cut back on their alcohol use. Join CEDEER’s Washington State Opioid Response Training Team for a training focusing on practical, evidence based approaches to alcohol withdrawal,…


April 1, 2026

RECORDING AVAILABLE: CEDEER Webinar: Harm Reduction in All Directions: Supporting the Workforce

Harm reduction in all directions: Supporting the workforce. CEDEER webinar. March 31, 2026, 11am-12pm PT

Update: This event was held on March 31, 2026. The slides & recording are now available. Harm reduction program staff serve an essential role in improving the health of people who use drugs. As front-line workers and first responders, they bring unique expertise and community connection to their work. However, their strengths and specialized needs…


March 10, 2026

CEDEER/SOR Webinar: What’s the Latest? Psychedelics for Opioid Use Disorder (March 30, 12pm PT)

ADAI webinar. What's the latest? Psychedelics for OPioid Use Disorder. Nathan Sackett, MD, MS. March 30, 2026, 12-1pm

Interest in the therapeutic use of psychedelics has grown rapidly in recent years—but what does the emerging research indicate about their role in treating opioid use disorder (OUD)? In this session, presented by Nathan Sackett, MD, MS, of ADAI’s Center for Novel Therapeutics in Addiction Psychiatry, we’ll explore the current evidence, potential mechanisms, safety considerations,…


March 6, 2026

Upcoming CEDEER Webinars: Incorporating Lived/Living Experience into SUD Clinical Design – A 3-Part Series

Incorporating lived/living experience into SUD clinical design: a three-part series

ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research’s State Opioid Response team is hosting a 3-part series showcasing how incorporating lived and living experience can transform substance use disorder (SUD) clinical design. Hear from facilitators, healthcare professionals, and community members who shape community advisory boards (CABs) and lived experience advisory boards (LEABs). Speakers and…


March 4, 2026

ADAI Lunch & Learn: Results from the 2025 WA State Syringe Services Program Health Survey (March 26, 2026, 12-1pm PT)

ADAI Lunch & Learn. Results from the 2025 WA State Syringe Services Program Health Survey. Alison Newman, MPH, UW ADAI. March 26, 2026, 12-1pm PT

What do people who receive services from syringe services programs (SSPs) have to say about their substance use patterns, health behaviors, and service use? What kinds of experiences have they had with healthcare, harm reduction, incarceration, and treatment? What care and services do they wish they could access? Join us on March 26, 2026 (12-1pm…


February 20, 2026

Northwest ATTC & CERP Webinar: Integrating Cannabis Use Prevention and Treatment into Primary Care (March 25, 12pm PT)

Northwest ATTC webinar March 25, 2026, 12pm PT: Integrating Cannabis Use Prevention and Treatment into Primary Care

Join the Northwest ATTC and the Cannabis Education & Research Program (CERP) at ADAI for this timely and informative webinar about cannabis! Integrating Cannabis Use Prevention and Treatment into Primary CareMarch 25, 2026 | 12-1pm PT | Register here Cannabis is one of the most widely used substances in the U.S., with notable rises in…


February 11, 2026

Northwest ATTC Webinar: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl (Feb. 25, 2026; CME available!)

ATTC/CTN Webinar Series: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl. February 25, 2026, 11am-12:30pm PT. 1.5 CME/CE Available.

Join the Northwest ATTC at ADAI, the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for their next joint webinar, February 25, 2026, 11am-12:30pm PT! In this session, Erin Winstanley, PhD (CTN Appalachian Node), will describe a NIDA Clinical Trials Network study, CTN-0135, examining clinician-reported challenges with initiating buprenorphine…



Previous page Next page